agilon health Inc (AGL)vsAstraZeneca PLC (AZN)
AGL
agilon health Inc
$85.12
-3.76%
HEALTHCARE · Cap: $1.43B
AZN
AstraZeneca PLC
$165.41
-0.76%
HEALTHCARE · Cap: $258.50B
Smart Verdict
WallStSmart Research — data-driven comparison
AstraZeneca PLC generates 937% more annual revenue ($61.37B vs $5.92B). AZN leads profitability with a 17.0% profit margin vs -3.9%. AZN earns a higher WallStSmart Score of 60/100 (C+).
AGL
Hold41
out of 100
Grade: D
AZN
Buy60
out of 100
Grade: C+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for AGL.
Margin of Safety
+14.6%
Fair Value
$195.23
Current Price
$165.41
$29.82 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Earnings expanding 301.0% YoY
Conservative balance sheet, low leverage
Mega-cap, among the largest globally
Every $100 of equity generates 21 in profit
Strong operational efficiency at 23.5%
Generating 2.1B in free cash flow
Areas to Watch
Distress zone — elevated risk
Smaller company, higher risk/reward
Operating margin of 1.3%
Weak financial health signals
2.5% earnings growth
Distress zone — elevated risk
Comparative Analysis Report
WallStSmart ResearchBull Case : AGL
The strongest argument for AGL centers on EPS Growth, Debt/Equity.
Bull Case : AZN
The strongest argument for AZN centers on Market Cap, Return on Equity, Operating Margin. Profitability is solid with margins at 17.0% and operating margin at 23.5%. PEG of 1.18 suggests the stock is reasonably priced for its growth.
Bear Case : AGL
The primary concerns for AGL are Altman Z-Score, Market Cap, Operating Margin.
Bear Case : AZN
The primary concerns for AZN are EPS Growth, Altman Z-Score.
Key Dynamics to Monitor
AGL profiles as a turnaround stock while AZN is a mature play — different risk/reward profiles.
AGL carries more volatility with a beta of 3.00 — expect wider price swings.
AGL is growing revenue faster at 7.2% — sustainability is the question.
AZN generates stronger free cash flow (2.1B), providing more financial flexibility.
Bottom Line
AZN scores higher overall (60/100 vs 41/100), backed by strong 17.0% margins. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
agilon health Inc
HEALTHCARE · MEDICAL CARE FACILITIES · USA
agilon health, inc. The company is headquartered in Long Beach, California.
Visit Website →AstraZeneca PLC
HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA
AstraZeneca PLC discovers, develops, manufactures and markets prescription drugs in the areas of oncology, cardiovascular, renal and metabolism, respiratory, infections, neuroscience and gastroenterology worldwide. The company is headquartered in Cambridge, the United Kingdom.
Compare with Other MEDICAL CARE FACILITIES Stocks
Want to dig deeper into these stocks?